Transcriptomics

Dataset Information

0

Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells: proof of principle and preliminary findings


ABSTRACT: Induced pluripotent stem cell (iPSC) technology has the potential to address the inaccessibility of the human brain by providing investigators with patient-specific neurons that can potentially be used to carry out molecular, electrophysiological and pharmacological studies {{855 Takahashi,K. 2006}}. Although iPSC technology was primarily conceived and developed as a means to bypass the use of human embryonic stem cells (hESCs) for regenerative medicine, its potential for disease modeling may prove to be equally valuable, especially for neuropsychiatric disorders. A total of 1207 genes were found to be differentially expressed using LIMMA (>2-fold, p-value <0.05), and these genes were hierarchically clustered to form 5 groups based on their expression in day 0, 10 and 32. These were subjected to bioinformatics analysis by Gene Ontogoly (GO) and Ingenuity Pathway Analysis (IPA) to determine enrichment profiles and associated disease processes. The largest cluster (cluster III), which showed increasing expression in both day 10 and day 32 neurons, was found to be enriched with genes involved in a number of neuronal pathways including neurogenesis, neuronal differentiation, axon guidance and adhesion, among others.

ORGANISM(S): Homo sapiens

PROVIDER: GSE26629 | GEO | 2011/01/14

SECONDARY ACCESSION(S): PRJNA136445

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2011-01-14 | E-GEOD-26629 | biostudies-arrayexpress
| phs001686 | dbGaP
2023-05-04 | E-MTAB-12402 | biostudies-arrayexpress
2018-12-24 | GSE124308 | GEO
| PRJNA309275 | ENA
2021-06-03 | GSE158089 | GEO
2012-10-25 | E-GEOD-40378 | biostudies-arrayexpress
| S-EPMC6645459 | biostudies-literature
2021-06-30 | GSE153325 | GEO
| EGAD00001011259 | EGA